Psychiatry
Psychiatric study for cancer patients to measure psychoactive medication
By Pankaj, US Correspondent
Dec 31, 2004, 01:22

Stage IV cancer patients who suffer from anxiety may want to investigate a research study approved by the Food and Drug Administration (FDA) taking place at LA BioMed. The specific aim of the study is to learn whether the psychoactive drug, psilocybin, might be effective in reducing anxiety, depression and physical pain, and therefore improving quality of life for Stage IV cancer patients. Psilocybin is a novel agent that produces a profound alteration in your state of consciousness.

The FDA recently approved a similar study at Harvard University to see whether the illegal drug ecstasy can ease the debilitating anxiety that cancer patients feel as they face their final days.

All rights reserved by www.rxpgnews.com